On 10 August 2020 media reported that Russia's Association of Clinical Trials Organizations which involves a number of major biopharmaceutical companies including Bayer, AstraZeneca, Novartis, made a proposal to postpone the state registration of the vaccine until the successful completion of the third phase of its clinical trials.[12][13]